Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FUT5 | Q11128 | 1/20 | 0.73 |
| ▸ | TGM2 | P21980 | 1/20 | 0.71 |
| ▸ | KRAS | P01116 | 2/20 | 0.67 |
| ▸ | NT5E | P21589 | 1/20 | 0.67 |
| ▸ | P2RY6 | Q15077 | 7/20 | 0.63 |
| ▸ | P2RY2 | P41231 | 6/20 | 0.63 |
| ▸ | P2RY4 | P51582 | 5/20 | 0.63 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.62 |
| ▸ | P2RY14 | Q15391 | 6/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29375573 | 1.00 | FUT5 (0.73) | FUT5TGM2KRASNT5EP2RY6 | |
| SCHEMBL29527687 | 1.00 | FUT5 (0.73) | FUT5TGM2KRASNT5EP2RY6 | |
| SCHEMBL30646153 | 1.00 | FUT5 (0.73) | FUT5TGM2KRASNT5EP2RY6 | |
| SCHEMBL29393705 | 1.00 | FUT5 (0.73) | FUT5TGM2KRASNT5EP2RY6 | |
| SCHEMBL29456613 | 1.00 | FUT5 (0.73) | FUT5TGM2KRASNT5EP2RY6 | |
| SCHEMBL30973673 | 1.00 | FUT5 (0.73) | FUT5TGM2KRASNT5EP2RY6 | |
| SCHEMBL29581866 | 1.00 | FUT5 (0.73) | FUT5TGM2KRASNT5EP2RY6 | |
| SCHEMBL29391942 | 1.00 | FUT5 (0.73) | FUT5TGM2KRASNT5EP2RY6 | |
| SCHEMBL29368655 | 0.99 | FUT5 (0.72) | FUT5TGM2KRASNT5EP2RY6 | |
| SCHEMBL25899459 | 0.94 | FUT5 (0.73) | FUT5TGM2KRASNT5EP2RY6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1052 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026100273-A1 | METHOD FOR PRODUCING USEFUL SUBSTANCE, CULTURE SOLUTION FOR CULTURING ALGAE, APPARATUS FOR PRODUCING USEFUL SUBSTANCE, AND ALGAE CONTAINING USEFUL SUBSTANCE | ＮＴＴ株式会社 | 2026-05-15 | — | — | WO | claimed |
| US-12624375-B2 | Methods for co-activating in vitro non-standard amino acid (nsAA) incorporation and glycosylation in crude cell lysates | NORTHWESTERN UNIVERSITY (US) | 2026-05-12 | — | — | US | claimed |
| US-20260092179-A1 | GENETICALLY MODIFIED HOST CELLS PRODUCING VIOLACEIN, ANALOGUES, AND DERIVATIVES THEREOF | OCTARINE BIO APS (DK) | 2026-04-02 | — | — | US | claimed |
| EP-4702138-A1 | PRODUCTION OF A NEGATIVELY CHARGED OLIGOSACCHARIDE BY A CELL | Inbiose N.V. (BE) | 2026-03-04 | — | — | EP | claimed |
| CN-121575022-A | Saccharomyces cerevisiae engineering bacteria for efficiently producing 2' -fucosyllactose, construction method and application thereof | 山东大学 | 2026-02-27 | — | — | CN | claimed |
| US-20250388948-A1 | CELL-FREE ENZYMATIC METHOD FOR PREPARATION OF N-GLYCANS | MAX PLANCK GESELLSCHAFT (DE) | 2025-12-25 | — | — | US | claimed |
| EP-4662305-A1 | PRODUCTION OF A DISACCHARIDE AND/OR MILK OLIGOSACCHARIDE BY A CELL WITH REDUCED SYNTHESIS OF UDP-GLCNAC | Inbiose N.V. (BE) | 2025-12-17 | — | — | EP | claimed |
| EP-4662224-A1 | PRODUCTION OF A SACCHARIDE BY A CELL WITH REDUCED SYNTHESIS OF LACTOBIONIC ACID | Inbiose N.V. (BE) | 2025-12-17 | — | — | EP | claimed |
| US-20250305018-A1 | SYNTHESIS OF GLYCOSYLATED HYDROXYTRYPTAMINE COMPOUNDS AND METHODS OF THEIR USE | CY BIOPHARMA AG (CH) | 2025-10-02 | — | — | US | claimed |
| EP-3461890-B1 | TOTAL FERMENTATION OF OLIGOSACCHARIDES | CHR HANSEN HMO GMBH (DE) | 2025-09-24 | — | — | EP | claimed |
| EP-3976769-A1 | GENETICALLY MODIFIED HOST CELLS PRODUCING GLYCOSYLATED CANNABINOIDS | Octarine Bio IVS (DK) | 2022-04-06 | — | — | EP | claimed |
| CN-114207108-A | Genetically modified host cells producing glycosylated cannabinoids | 奥克塔林生物制剂公司 | 2022-03-18 | — | — | CN | claimed |
| CN-111471606-B | Optimized saccharomyces cerevisiae strain capable of producing fucosyllactose at high yield and application thereof | 山东大学 | 2022-03-08 | — | — | CN | claimed |
| CN-108754018-B | Screening method and application of acanthopanax senticosus target gene SSR molecular marker | 大连民族大学 | 2022-03-04 | — | — | CN | claimed |
| CN-114107152-A | Construction method and application of high-yield 3-fucosyllactose microorganism | 江南大学 | 2022-03-01 | — | — | CN | claimed |
| WO-2022040411-A2 | BIOSYNTHETIC PRODUCTION OF 2-FUCOSYLLACTOSE | CONAGEN INC. (US) | 2022-02-24 | — | — | WO | claimed |
| WO-2022034075-A1 | PRODUCTION OF GLCNAC CONTAINING BIOPRODUCTS IN A CELL | INBIOSE N.V. (BE) | 2022-02-17 | — | — | WO | claimed |
| WO-2022034076-A2 | PRODUCTION OF GALACTOSYLATED DI- AND OLIGOSACCHARIDES | INBIOSE N.V. (BE) | 2022-02-17 | — | — | WO | claimed |
| WO-2022034069-A1 | PRODUCTION OF A MIXTURE OF NEUTRAL FUCOSYLATED OLIGOSACCHARIDES BY A CELL | INBIOSE N.V. (BE) | 2022-02-17 | — | — | WO | claimed |
| CN-113957027-A | Genetic engineering bacterium for improving yield of lactoyl-N-fucohexaose and production method thereof | 江南大学 | 2022-01-21 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260092179-A1 | GENETICALLY MODIFIED HOST CELLS PRODUCING VIOLACEIN, ANALOGUES, AND DERIVATIVES THEREOF | TDO2, BLVRB, INMT | FUT5 2018/4885TGM2 1375/4885KRAS 3448/4885 |
| US-20250388948-A1 | CELL-FREE ENZYMATIC METHOD FOR PREPARATION OF N-GLYCANS | MAN2A1, ENGASE, MAN2B1 | FUT5 23/4885TGM2 399/4885KRAS 2421/4885 |
| US-12624375-B2 | Methods for co-activating in vitro non-standard amino acid (nsAA) incorporation and glycosylation in crude cell lysates | RNGTT, FEN1, SEC11A | FUT5 971/4885TGM2 820/4885KRAS 3027/4885 |
| US-20250305018-A1 | SYNTHESIS OF GLYCOSYLATED HYDROXYTRYPTAMINE COMPOUNDS AND METHODS OF THEIR USE | TPH1, TPH2, HTR1A | FUT5 72/4885TGM2 1025/4885KRAS 4491/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.